The invention
Circulating Thrombospondin-2 (TSP2) - A novel fibrosis biomarker for patients with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease
M: Medicine – Surgery – Orthopaedics – Material for disabled
Informations
- Stand number
- B81
- Exhibition class
- M: Medicine – Surgery – Orthopaedics – Material for disabled
- Technical description
- Circulating thrombospondin-2 levels as a simple and non-invasive blood biomarker to predict the presence and development of advanced liver fibrosis, a crucial stage of steatotic liver disease impacting the progression.
- Simplified description
- Thrombospondin-2 is a protein that can be measured in the blood. Its level can indicate whether a person has advanced hepatic fibrosis, a serious liver disease linked to hepatic steatosis. It's a simple, painless way of predicting and monitoring the progress of this liver disease.
Inventors
Aimin XU
inventor 3727293077_3315
Karen Siu-Ling LAM
inventor 3727293077_3314
Chi-Ho LEE
inventor 3727293077_3313
The University of Hong Kong
inventor 3727293077_3106
Information in this online catalogue is based on data received for the Event and updated by the participant. Catalogue entries remain the sole responsability of the participant. The Exhibition management declines all responsibility for any possible errors or omissions.